CD8A and B-cell chronic lymphocytic leukemia: In addition, the exposure of CAR-T cells to duvelisib has been demonstrated to improve the effectiveness of CAR-T cells in the elimination of CLL in vitro and vivo studies by enriching CD8+ CAR-T cells [264].